Wed, August 31, 2022
Tue, August 30, 2022
Mon, August 29, 2022
Sun, August 28, 2022
Fri, August 26, 2022
Thu, August 25, 2022
Wed, August 24, 2022
Tue, August 23, 2022
Mon, August 22, 2022
Fri, August 19, 2022
Thu, August 18, 2022

Raghuram Selvaraju Maintained (BTAI) at Strong Buy with Decreased Target to $85 on, Aug 24th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-85-on-aug-24th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Raghuram Selvaraju of HC Wainwright & Co., Maintained "BioXcel Therapeutics, Inc." (BTAI) at Strong Buy with Decreased Target from $110 to $85 on, Aug 24th, 2022.

Raghuram has made no other calls on BTAI in the last 4 months.



There are 2 other peers that have a rating on BTAI. Out of the 2 peers that are also analyzing BTAI, 0 agree with Raghuram's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Raghuram


  • Graig Suvannavejh of "Mizuho" Initiated at Strong Buy and Held Target at $19 on, Thursday, July 7th, 2022
  • Corinne Jenkins of "Goldman Sachs" Maintained at Strong Sell with Decreased Target to $10 on, Monday, May 9th, 2022

Publication Contributing Sources